USE OF A HETEROCYCLIC BCL-2 INHIBITOR FOR REMOVING SENESCENT CELLS AND TREATING SENESCENCE-ASSOCIATED CONDITIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15611589

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed herein are compounds that are effective for treatment of various disease states. Dosing includes both single administration and regimens of cycling dosages.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNITY BIOTECHNOLOGY INC3280 BAYSHORE BLVD BRISBANE CA 94005

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
David, Nathaniel San Francisco, US 43 344
Laberge, Remi-Martin S. San Francisco, US 42 367

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation